These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8960113)
1. Immunological properties of the thymopentin-like fragments of HLA-DQ. Szewczuk Z; Siemion IZ; Wieczorek Z Mol Immunol; 1996 Aug; 33(11-12):903-8. PubMed ID: 8960113 [TBL] [Abstract][Full Text] [Related]
2. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs. Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010 [TBL] [Abstract][Full Text] [Related]
3. The immunosuppressory and adhesive miniregion of the human major histocompatibility protein, human leukocyte antigen DQ. Szewczuk Z; Stefanowicz P; Wilczyński A; Siemion IZ; Cierniewski CS; Kralisz U; Wieczorek Z Biopolymers; 1996; 40(5):571-83. PubMed ID: 9062075 [TBL] [Abstract][Full Text] [Related]
5. New conformationally restricted analog of the immunosuppressory mini-domain of HLA-DQ and its biological properties. Szewczuk Z; Wilczyński A; Dyba M; Petry I; Siemion IZ; Wieczorek Z Peptides; 2000 Dec; 21(12):1849-58. PubMed ID: 11150645 [TBL] [Abstract][Full Text] [Related]
7. Threonine at position 6 is not essential for the immunosuppressive activity of HLA-DQ(beta164-172)-hexapeptide. Stefanowicz P; Boratyński PJ; Staszewska A; Wilczyński A; Zimecki M; Szewczuk Z Mol Immunol; 2004 Jul; 41(9):911-7. PubMed ID: 15261463 [TBL] [Abstract][Full Text] [Related]
8. HLA-DQ7 beta(1) and beta(2) derived peptides as immunomodulators. Skarlas T; Panou-Pomonis E; Kluczyk A; Szewczuk Z; Zimecki M; Kosmopoulou A; Sakarellos-Daitsiotis M; Sakarellos C J Pept Sci; 2009 Apr; 15(4):296-304. PubMed ID: 19206073 [TBL] [Abstract][Full Text] [Related]
9. HLA-DQB1 codon 57 is critical for peptide binding and recognition. Kwok WW; Domeier ME; Johnson ML; Nepom GT; Koelle DM J Exp Med; 1996 Mar; 183(3):1253-8. PubMed ID: 8642268 [TBL] [Abstract][Full Text] [Related]
10. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011. Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624 [TBL] [Abstract][Full Text] [Related]
11. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR. Paliakasis K; Routsias J; Petratos K; Ouzounis C; Kokkinidis M; Papadopoulos GK J Struct Biol; 1996; 117(2):145-63. PubMed ID: 8931340 [TBL] [Abstract][Full Text] [Related]
12. Structural aspects of the interaction between heterogeneic human papillomavirus type 1 E4-specific T cell receptors and the same peptide/HLA-DQ8 complex. Steele JC; Young SP; Goodall JC; Gallimore PH J Immunol; 1998 Nov; 161(9):4745-52. PubMed ID: 9794405 [TBL] [Abstract][Full Text] [Related]
13. Revisiting the structural basis and energetic landscape of susceptibility difference between HLA isotypes to allergic rhinitis. Mao XL; Zhu F; Pan ZH; Wu GM; Zhu HY Comput Biol Chem; 2016 Oct; 64():210-216. PubMed ID: 27433817 [TBL] [Abstract][Full Text] [Related]
14. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890 [TBL] [Abstract][Full Text] [Related]
15. Generation of rabbit antipeptide antibodies to HLA-class II antigens by the use of synthetic peptides. Chersi A; Morganti MC; Chillemi F; Houghten R; Cenciarelli C Clin Exp Immunol; 1988 Jul; 73(1):76-81. PubMed ID: 3168331 [TBL] [Abstract][Full Text] [Related]
16. DQ 65-79, a peptide derived from HLA class II, mimics p21 to block T cell proliferation. Dong C; Lyu SC; Krensky AM; Clayberger C J Immunol; 2003 Nov; 171(10):5064-70. PubMed ID: 14607903 [TBL] [Abstract][Full Text] [Related]
17. Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells. Pancré V; Georges B; Angyalosi G; Castelli F; Delanoye A; Delacre M; Hachulla E; Maillere B; Bouzidi A; Auriault C Clin Exp Immunol; 2002 Sep; 129(3):429-37. PubMed ID: 12197883 [TBL] [Abstract][Full Text] [Related]
18. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires. Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585 [TBL] [Abstract][Full Text] [Related]
19. Critical contribution of beta chain residue 57 in peptide binding ability of both HLA-DR and -DQ molecules. Nepom BS; Nepom GT; Coleman M; Kwok WW Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7202-6. PubMed ID: 8692969 [TBL] [Abstract][Full Text] [Related]
20. Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding. Audhya T; Heavner GA; Kroon DJ; Goldstein G Regul Pept; 1984 Oct; 9(3):155-64. PubMed ID: 6098937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]